Under his tenure, he created the breakthrough devices program, a pathway that has become immensely popular for device makers seeking expedited approval and reimbursement. Shuren dramatically increased the number of medical devices authorized by the FDA each year — by five-fold, according to Commissioner Rob Califf’s email announcing the news.